Laird Norton Wetherby Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.82M | Buy |
19,151
+1,090
| +6% | +$100K | 0.07% | 244 |
|
|
2025
Q2 | $1.57M | Buy |
+18,061
| New | +$1.53M | 0.07% | 260 |
|
|
2024
Q4 | $1.58M | Buy |
19,840
+1,232
| +7% | +$107K | 0.08% | 240 |
|
|
2024
Q3 | $1.68M | Sell |
18,608
-409
| -2% | -$34.4K | 0.08% | 251 |
|
|
2024
Q2 | $1.5M | Sell |
19,017
-693
| -4% | -$56.8K | 0.07% | 262 |
|
|
2024
Q1 | $1.72M | Buy |
19,710
+1,442
| +8% | +$123K | 0.08% | 252 |
|
|
2023
Q4 | $1.5M | Sell |
18,268
-6,107
| -25% | -$465K | 0.08% | 256 |
|
|
2023
Q3 | $1.91M | Sell |
24,375
-716
| -3% | -$59.9K | 0.11% | 190 |
|
|
2023
Q2 | $2.21M | Sell |
25,091
-223
| -0.9% | -$19.2K | 0.12% | 171 |
|
|
2023
Q1 | $2.04M | Buy |
25,314
+7,728
| +44% | +$630K | 0.12% | 179 |
|
|
2022
Q4 | $1.37M | Sell |
17,586
-6,567
| -27% | -$532K | 0.09% | 256 |
|
|
2022
Q3 | $1.95M | Buy |
24,153
+267
| +1% | +$24K | 0.14% | 151 |
|
|
2022
Q2 | $2.14M | Sell |
23,886
-2,750
| -10% | -$279K | 0.15% | 135 |
|
|
2022
Q1 | $2.96M | Buy |
26,636
+3,417
| +15% | +$361K | 0.17% | 109 |
|
|
2021
Q4 | $2.4M | Sell |
23,219
-1,537
| -6% | -$178K | 0.13% | 139 |
|
|
2021
Q3 | $3.1M | Sell |
24,756
-211
| -0.8% | -$27.3K | 0.19% | 102 |
|
|
2021
Q2 | $3.1M | Buy |
24,967
+4,453
| +22% | +$559K | 0.19% | 100 |
|
|
2021
Q1 | $2.42M | Sell |
20,514
-3,124
| -13% | -$366K | 0.18% | 102 |
|
|
2020
Q4 | $2.77M | Buy |
23,638
+2,312
| +11% | +$255K | 0.19% | 100 |
|
|
2020
Q3 | $2.22M | Buy |
21,326
+209
| +1% | +$21K | 0.2% | 100 |
|
|
2020
Q2 | $1.94M | Buy |
21,117
+1,869
| +10% | +$179K | 0.18% | 110 |
|
|
2020
Q1 | $1.74M | Sell |
19,248
-3,647
| -16% | -$388K | 0.19% | 109 |
|
|
2019
Q4 | $2.6M | Buy |
22,895
+648
| +3% | +$71.1K | 0.26% | 87 |
|
|
2019
Q3 | $2.42M | Buy |
22,247
+832
| +4% | +$86.8K | 0.25% | 86 |
|
|
2019
Q2 | $2.09M | Buy |
21,415
+1,663
| +8% | +$152K | 0.23% | 100 |
|
|
2019
Q1 | $1.8M | Buy |
19,752
+373
| +2% | +$33.4K | 0.22% | 102 |
|
|
2018
Q4 | $1.76M | Buy |
19,379
+894
| +5% | +$83.5K | 0.25% | 85 |
|
|
2018
Q3 | $1.82M | Buy |
18,485
+498
| +3% | +$46K | 0.22% | 99 |
|
|
2018
Q2 | $1.54M | Sell |
17,987
-291
| -2% | -$24.3K | 0.21% | 105 |
|
|
2018
Q1 | $1.47M | Buy |
18,278
+1,399
| +8% | +$115K | 0.2% | 107 |
|
|
2017
Q4 | $1.36M | Sell |
16,879
-164
| -1% | -$13.1K | 0.19% | 117 |
|
|
2017
Q3 | $1.32M | Sell |
17,043
-1,429
| -8% | -$119K | 0.2% | 109 |
|
|
2017
Q2 | $1.64M | Buy |
18,472
+2,531
| +16% | +$213K | 0.28% | 73 |
|
|
2017
Q1 | $1.28M | Buy |
15,941
+3,538
| +29% | +$276K | 0.23% | 94 |
|
|
2016
Q4 | $883K | Sell |
12,403
-4,053
| -25% | -$318K | 0.17% | 133 |
|
|
2016
Q3 | $1.42M | Buy |
16,456
+738
| +5% | +$64.3K | 0.29% | 69 |
|
|
2016
Q2 | $1.36M | Buy |
15,718
+525
| +3% | +$42.5K | 0.3% | 67 |
|
|
2016
Q1 | $1.14M | Buy |
15,193
+1,338
| +10% | +$101K | 0.27% | 79 |
|
|
2015
Q4 | $1.07M | Buy |
13,855
+6,360
| +85% | +$479K | 0.26% | 86 |
|
|
2015
Q3 | $502K | Sell |
7,495
-8,126
| -52% | -$598K | 0.13% | 189 |
|
|
2015
Q2 | $1.16M | Sell |
15,621
-4,254
| -21% | -$325K | 0.28% | 75 |
|
|
2015
Q1 | $1.55M | Buy |
19,875
+5,290
| +36% | +$401K | 0.38% | 53 |
|
|
2014
Q4 | $1.05M | Buy |
14,585
+430
| +3% | +$29.9K | 0.26% | 75 |
|
|
2014
Q3 | $877K | Buy |
14,155
+15
| +0.1% | +$954 | 0.24% | 90 |
|
|
2014
Q2 | $902K | Sell |
14,140
-551
| -4% | -$33.5K | 0.25% | 89 |
|
|
2014
Q1 | $904K | Sell |
14,691
-38
| -0.3% | -$2.21K | 0.26% | 86 |
|
|
2013
Q4 | $845K | Buy |
14,729
+4
| +0% | +$227 | 0.24% | 98 |
|
|
2013
Q3 | $784K | Buy |
14,725
+224
| +2% | +$12.1K | 0.24% | 96 |
|
|
2013
Q2 | $746K | Buy |
+14,501
| New | +$717K | 0.26% | 87 |
|
Other funds holding MDT
Laird Norton Wetherby Wealth Management's MDT Position: Q3 2025 in Review
Laird Norton Wetherby Wealth Management increased its Medtronic (MDT) stake by 6% in Q3 2025, buying an estimated $100K and bringing the position to 19,151 shares worth $1.82M. The position accounts for 0.07% of the portfolio, ranked #244.
Laird Norton Wetherby Wealth Management first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $3.1M in Q3 2021. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Laird Norton Wetherby Wealth Management held 19,151 shares of Medtronic worth $1.82M as of Q3 2025.
- Laird Norton Wetherby Wealth Management bought 1,090 Medtronic shares in Q3 2025, an estimated $100K.
- Medtronic made up 0.07% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #244 holding.
- Laird Norton Wetherby Wealth Management first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
- Laird Norton Wetherby Wealth Management's Medtronic position peaked at $3.1M in Q3 2021.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.